LASREKIBART
UNII UP8FP5L8D6

Substance Identification & Data

This profile provides standardized clinical and technical data for Lasrekibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UP8FP5L8D6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3021525-26-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UP8FP5L8D6
CAS Registry Number
3021525-26-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LASREKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C215271
National Cancer Institute reference terminology for clinical and research data.
INN ID
13500
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lasrekibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LASREKIBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV3-23*02 (88.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14, 9-G1V21 CH2 Y15.1, T16, E18 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 M15.1>Y (253), S16>T (255), T18>E (257) (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214')(V-KAPPA (HOMO SAPIENS IGKV1-6*01 (84.0%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (253-TYROSINE,255-THREONINE,257-GLUTAMIC ACID), ANTI-(HUMAN INTERLEUKIN-5) (HUMAN-RATTUS NORVEGICUS MONOCLONAL HRP00488 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL HRP00488 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL5 (INTERLEUKIN 5, IL-5)), HUMANIZED MONOCLONAL ANTIBODY (LASREKIBART)
LASREKIBART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus